INFIFORCE's Isabella Bai at CES 2026: China is Moving from Manufacturing to Defining Next-Gen Embodied Intelligence
LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- Isabella Bai, Founder and CEO of INFIFORCE, has pointed out the core bottleneck of AI industry at the "Not Quite Human: How Humanoids are Changing Work and Home Life" panel during CES 2026, stating that now...
STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy
SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- STARMED, a pioneer in innovative minimally invasive treatment solutions, has announced a comprehensive rebranding. Now in its seventeenth year of operation, the company is formally transitioning from...
BlueSG Receives Frost & Sullivan's 2025 Asia-Pacific Customer Value Leadership Recognition for Excellence in Car-sharing Industry
Frost & Sullivan applauds BlueSG's customer-centric approach, digital transformation, and operational agility in redefining urban mobility through its innovative car-sharing model. SAN ANTONIO, Jan. 6, 2026 /PRNewswire/ -- Frost & Sullivan...
AI+AR Leads a New Chapter in Human-Computer Interaction
MACAO, Dec. 16, 2025 /PRNewswire/ -- Driven by the rapid maturation of multimodal perception, spatial computing, micro-displays, and other technologies, AI glasses, as the next-generation human-computer interaction terminal, are transitioning from...
CQ Medical® Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition
AVONDALE, Pa., Dec. 2, 2025 /PRNewswire/ -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy business unit, marking an expansion of its...
Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence
The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name. SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI...
PharmaResearch Spin-Off into Holding and Aesthetics Companies Approved by Board of Directors
SEONGNAM, South Korea, June 13, 2025 /PRNewswire/ -- PharmaResearch announced on June 13 that its board of directors has approved a corporate spin-off, resulting in the formation of two distinct entities: PharmaResearch Holdings, which will remain...
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid tablets for...